908 Devices (NASDAQ:MASS) Earns “Sell (E+)” Rating from Weiss Ratings

908 Devices (NASDAQ:MASS)‘s stock had its “sell (e+)” rating reiterated by Weiss Ratings in a research note issued on Saturday,Weiss Ratings reports.

A number of other research firms also recently weighed in on MASS. Stifel Nicolaus decreased their price target on shares of 908 Devices from $17.00 to $6.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Stephens reissued an “overweight” rating and set a $6.00 price objective on shares of 908 Devices in a report on Wednesday. Leerink Partners restated a “market perform” rating and issued a $4.00 target price (down from $12.00) on shares of 908 Devices in a research note on Wednesday, November 13th. Finally, Leerink Partnrs cut 908 Devices from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 13th. Two equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $5.33.

908 Devices Stock Performance

Shares of 908 Devices stock traded up $0.08 during mid-day trading on Friday, hitting $2.98. 1,347,475 shares of the stock were exchanged, compared to its average volume of 369,045. The company has a 50-day simple moving average of $2.36 and a 200 day simple moving average of $3.50. 908 Devices has a 12 month low of $1.81 and a 12 month high of $8.50. The company has a market capitalization of $103.76 million, a P/E ratio of -1.68 and a beta of 0.96.

Institutional Trading of 908 Devices

Institutional investors and hedge funds have recently modified their holdings of the business. SG Americas Securities LLC purchased a new stake in 908 Devices in the third quarter valued at approximately $36,000. B. Riley Wealth Advisors Inc. purchased a new stake in shares of 908 Devices during the 3rd quarter valued at $45,000. Drive Wealth Management LLC bought a new stake in shares of 908 Devices during the 3rd quarter worth $50,000. Townsquare Capital LLC purchased a new position in 908 Devices in the third quarter worth $50,000. Finally, 49 Wealth Management LLC increased its stake in 908 Devices by 16.2% in the third quarter. 49 Wealth Management LLC now owns 31,099 shares of the company’s stock valued at $108,000 after acquiring an additional 4,343 shares during the last quarter. Hedge funds and other institutional investors own 88.06% of the company’s stock.

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.